Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3046682	sk-if-iga	— (—)	65	67	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis

38.26

68.48

1.0

1.1

—

Dermatitis and eczema

26.37

47.68

1.0

1.1

—

Other and unspecified dermatitis

40.09

32.05

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

+∞

19.48

1.0

0.0

—

Atopic dermatitis

23.89

14.27

1.0

1.1

—

Atopic dermatitis, strict definition

10.40

9.12

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

4.69

8.85

1.0

—

Autoimmune diseases excluding thyroid diseases

4.52

8.50

1.0

—

Lichen simplex chronicus and prurigo

+∞

7.29

1.0

0.0

—

ILD medications: immunosuppressive drugs

4.28

6.59

1.0

1.1

—

Inflammatory bowel disease treatment related agents

3.27

5.37

1.0

—

L04AX Other immunosuppressants

3.75

5.07

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.24

4.86

1.0

—

Second line medication for Crohn's disease

3.57

4.74

1.0

—

Other diseases of lip and oral mucosa

5.00

4.31

1.1

1.0

—

ILD medications

2.98

4.26

1.0

1.1

—

Autoimmune diseases

3.21

4.23

1.1

1.0

—

First line medication for Crohn's disease

2.83

3.76

1.0

1.1

—

Oral corticosteroids

2.85

3.73

1.0

—

Urticaria and erythema

4.40

3.61

1.0

1.1

—

Cystitis

2.88

3.23

1.1

1.0

—

Disorders of conjunctiva

2.64

2.82

1.0

—

Diseases of oral cavity, salivary glands and jaws

4.64

2.82

1.0

—

Conjunctivitis

2.68

2.73

1.0

—

Certain infectious and parasitic diseases, including avohilmo

2.96

2.61

1.0

—

Other gastritis (incl. Duodenitis)

5.46

2.54

1.0

1.1

—

Used for control exclusion in common control thyroid runs

2.61

2.47

1.1

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.33

2.46

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

5.00

2.40

1.0

—

Diseases of oesophagus, stomach and duodenum

2.33

2.38

1.0

—

Other diseases of hard tissues of teeth

4.14

2.35

1.0

—

Rheumatism, unspecified

5.56

2.21

1.0

1.1

—

Coeliac disease

5.56

2.21

1.0

1.1

—

Medical abortion

2.71

2.16

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.82

2.15

1.0

1.1

—

Exposure to unspecified factor

2.22

2.10

1.1

1.0

—

Pregnancy with abortive outcome

2.60

2.01

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.90

2.00

1.0

—

Diverticular disease of intestine

2.63

1.98

1.0

—

Urticaria

3.33

1.96

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.18

1.89

1.0

—

Papulosquamous disorders

3.18

1.88

1.0

—

Lichen planus, including avohilmo

4.17

1.82

1.0

1.1

—

Autoimmune diseases related-to ILD

2.21

1.80

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

3.04

1.79

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.10

1.77

1.0

—

Gastrointestinal diseases

2.78

1.75

1.0

—

Other menopausal disorders

3.72

1.75

1.0

—

External causes of morbidity and mortality

2.41

1.74

1.1

1.0

—

Dental operations

2.94

1.74

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

2.17

1.72

1.0

1.1

—

Acetic acid derivatives and related substances

4.31

1.66

1.0

—

Other specified/unspecified arthritis

3.16

1.66

1.0

—

Diseases of the eye and adnexa

2.25

1.65

1.1

1.0

—

Accidents

2.25

1.65

1.1

1.0

—

Disease of hard tissues of teeth, NOS

3.49

1.64

1.0

—

Pain in joint

2.46

1.62

1.0

—

Allergic conjunctivitis

2.40

1.62

1.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

3.57

1.61

1.0

1.1

—

Other and unspecified urticaria

3.57

1.61

1.0

1.1

—

Sleep apnoea

2.16

1.61

1.0

—

Abdominal and pelvic pain

2.13

1.59

1.0

—

Systemic connective tissue disorders

3.00

1.58

1.0

1.1

—

Fever of other and unknown origin

2.28

1.54

1.0

—

Other diseases of urinary system

2.07

1.53

1.1

1.0

—

Cerebrovascular diseases (FINNGEN)

3.00

1.51

1.0

—

Other arthritis (FG)

2.86

1.50

1.0

—

Any reimbursement code in KELA

2.30

1.47

1.0

—

Tooth eruption problems

3.22

1.47

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.36

1.45

1.0

—

Injury, poisoning and certain other consequences of external causes

2.39

1.44

1.0

—

Psoriasis

3.13

1.44

1.0

1.1

—

Candidiasis, including avohilmo

2.73

1.43

1.0

—

Extrapyramidal and movement disorders

2.73

1.43

1.0

—

Other diseases of anus and rectum

3.11

1.43

1.0

1.1

—

Persons encountering health services in other circumstances

2.47

1.43

1.0

—

Other abnormal uterine and vaginal bleeding

3.27

1.43

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.57

1.34

1.0

—

Erysipelas, including avohilmo

2.15

1.31

1.0

—

Spontaneous abortion

2.43

1.31

1.0

—

Certain infectious and parasitic diseases

1.95

1.31

1.0

—

Other external causes of accidental injury

2.07

1.30

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.10

1.30

1.0

—

Missing teeth due to accident, extraction or parodontitis

2.38

1.29

1.0

—

Other bacterial diseases, including avohilmo

1.90

1.29

1.0

—

Viral warts, including avohilmo

2.78

1.28

1.2

1.1

—

Diseases of liver

2.78

1.28

1.0

1.1

—

Noninflammatory disorders of female genital tract

2.36

1.26

1.0

—

Other disorders of skin and subcutaneous tissue

2.02

1.26

1.1

1.0

—

Diseases of pulp and periapical tissues and dental caries

2.28

1.22

1.0

1.1

—

Other septicaemia

2.62

1.20

1.0

1.1

—

Acute suppurative otitis media

2.33

1.19

1.0

—

Intestinal infectious diseases

1.86

1.18

1.1

1.0

—

Viral and other specified intestinal infections, including avohilmo

2.53

1.16

1.0

—

Acute upper respiratory infections

1.82

1.16

1.0

—

Disorders of skin appendages

2.04

1.14

1.0

—

Other septicaemia, including avohilmo

2.47

1.13

1.0

1.1

—

Suppurative and unspecified otitis media

2.30

1.11

1.0

—

Erysipelas

2.23

1.09

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.38

1.09

1.0

—

Caries of dentine, including avohilmo

2.09

1.08

1.0

1.1

—

Other degenerative diseases of the nervous system

2.43

1.07

1.0

1.1

—

Unspecified fall

2.15

1.06

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.94

1.06

1.1

1.0

—

Other disorders of urethra and urinary system

2.02

1.05

1.0

—

Benign neoplasms

1.77

1.05

1.0

—

Septicaemia

2.28

1.02

1.0

1.1

—

Insomnia

1.81

1.02

1.0

—

Persons encountering health services in other circumstances, wide

1.75

1.01

1.0

—

Other disorders of veins

2.24

1.01

1.0

—

Other antidepressants

1.79

1.00

1.0

—

Headache

1.88

1.00

1.1

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

2.00

0.99

1.0

—

Other and unspecified iron deficiency

2.17

0.98

1.0

—

Postpartum haemorrhage

0.00

0.97

0.0

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.82

0.97

1.0

—

Triptan medication for migraine, min. 3 purchases

1.82

0.96

1.0

—

Postpartum hemorraghe, all women as controls

0.00

0.95

0.0

1.0

—

Contact with and exposure to communicable diseases

2.21

0.93

1.0

1.1

—

Explicit Sepsis

2.18

0.92

1.0

—

Complications of medical and surgical care

1.83

0.92

1.0

—

Diseases of the digestive system

2.13

0.91

1.0

—

Cerebrovascular diseases

1.98

0.91

1.0

—

Complications of procedures, not elsewhere classified

1.77

0.90

1.0

—

Dental caries, including avohilmo

1.95

0.90

1.0

1.1

—

Explicit Sepsis, including avohilmo

2.09

0.89

1.0

—

Infections with a predominantly sexual mode of transmission

2.06

0.89

1.0

—

Ischaemic heart disease, wide definition

1.89

0.88

1.0

—

Iron deficiency anaemia

2.03

0.88

1.0

—

Antihypertensive medication - note that there are other indications

1.87

0.87

1.0

—

Necrosis of pulp, including avohilmo

1.84

0.86

1.0

—

Other and unspecified tonsillitis

1.99

0.86

1.0

—

Persons with potential health hazards related to communicable diseases

1.98

0.86

1.0

1.1

—

Gastro-oesophageal reflux disease

1.82

0.86

1.0

—

Inguinal hernia

1.99

0.85

1.0

1.1

—

Dorsopathies

1.65

0.84

1.0

—

Infections of the skin and subcutaneous tissue

1.75

0.82

1.0

—

Pregnancy, childbirth and the puerperium

0.00

0.82

0.0

1.0

—

Falls/tendency to fall

1.63

0.81

1.0

—

Noninfective enteritis and colitis

1.87

0.81

1.2

1.0

—

Maternal care for other known or suspected fetal problems

1.88

0.80

1.0

—

Presence of other functional implants

1.87

0.80

1.0

—

Transport accidents

1.85

0.80

1.2

1.0

—

Hyperlipidaemia, other/unspecified

0.00

0.79

0.0

1.0

—

Bacterial pneumonia (organism specified)

0.00

0.79

0.0

1.0

—

Disorders of refraction and accommodation

0.00

0.79

0.0

1.1

—

HSIL lesion of the cervix uteri

0.00

0.79

0.0

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.79

0.0

1.0

—

Abrasion of teeth

0.00

0.79

0.0

1.0

—

Other diseases of pleura

0.00

0.79

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.79

0.0

1.0

—

1.61

0.79

1.0

—

Abnormalities of heart beat

0.00

0.78

0.0

1.0

—

Non-invasive ventilation

0.00

0.77

0.0

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.74

0.77

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.68

0.77

1.0

—

Other symptoms and signs involving cognitive functions and awareness

0.00

0.77

0.0

1.0

—

Asthma, including avohilmo

1.57

0.74

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.84

0.73

1.0

—

Complications predominantly related to the puerperium

2.00

0.72

1.0

—

Other bacterial diseases

1.65

0.72

1.0

—

Sleep disorders

1.65

0.71

1.0

—

Coronary atherosclerosis

1.77

0.71

1.0

—

General symptoms and signs

1.59

0.70

1.0

—

Dental pulpitis, including avohilmo

1.60

0.70

1.0

—

Use of hypnotics and sedatives

0.53

0.70

1.0

—

Reimbursement for rheumatic diseases

1.70

0.69

1.0

—

Leiomyoma of uterus

1.71

0.69

1.0

—

Haemorrhage in early pregnancy

1.87

0.69

1.0

—

Examination and observation for other reasons

1.64

0.66

1.0

—

Hernia of abdominal wall

1.79

0.66

1.0

—

Urinary track infection

1.74

0.65

1.0

—

Ovarian cyst

1.79

0.64

1.0

—

Persons encountering health services for examination and investigation

1.67

0.64

1.0

—

Injuries to the thorax

1.72

0.63

1.0

—

Hypertension, essential

1.61

0.62

1.1

1.0

—

Care involving use of rehabilitation procedures

1.63

0.62

1.1

1.0

—

Neurological diseases, wide definition

1.88

0.61

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

0.00

0.61

0.0

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.61

0.0

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.59

0.61

1.0

—

Prolonged pregnancy

0.00

0.60

0.0

1.0

—

Benign thyroid growths and nodules

0.00

0.60

0.0

1.1

—

Other hearing loss

0.00

0.60

0.0

1.1

—

Myocardial infarction, without ST-elevation

0.00

0.60

0.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.56

0.60

1.0

—

Sub-endpoint used in defining T1D endpoints

0.00

0.60

0.0

1.1

—

Lyme disease

0.00

0.60

0.0

1.1

—

Lyme disease, including avohilmo

0.00

0.60

0.0

1.1

—

Bacterial pneumonia, not elsewhere classified

0.00

0.60

0.0

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

0.00

0.60

0.0

1.0

—

Other spirochaetal diseases

0.00

0.60

0.0

1.0

—

Other spirochaetal diseases, including avohilmo

0.00

0.60

0.0

1.0

—

Postpartum hemorraghe, parous women as controls

0.00

0.59

0.0

1.1

—

Hallux valgus (acquired)

0.00

0.59

0.0

1.0

—

Pain (limb, back, neck, head abdominally)

1.54

0.59

1.0

—

Ischemic heart diseases

1.54

0.59

1.0

—

Irritable bowel syndrome

0.00

0.59

0.0

1.0

—

Bacterial pneumoniae

0.00

0.59

0.0

1.1

—

Spondylopathies

1.53

0.59

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.55

0.58

1.0

—

Diabetes mellitus

0.57

0.58

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

1.75

0.58

1.0

—

Fracture of forearm

1.74

0.58

1.2

1.0

—

Medicines for HER+ breast cancer

0.00

0.58

0.0

1.0

—

Episodal and paroxysmal disorders

1.50

0.57

1.0

—

Acute appendicitis

1.48

0.57

1.0

—

STROKE

1.68

0.57

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

1.48

0.57

1.0

—

Other obstetric conditions, not elsewhere classified

1.65

0.56

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.64

0.56

1.0

—

Bacterial infection, other or unspecified, including avohilmo

1.64

0.56

1.0

—

Malaise and fatigue

1.63

0.55

1.0

—

Parasetamol

1.52

0.55

1.0

—

Selective serotonin reuptake inhibitors

1.54

0.55

1.0

—

Other inflammation of eyelid, including avohilmo

1.62

0.55

1.0

—

Nutritional anaemias

1.59

0.54

1.0

—

Single spontaneous delivery

1.58

0.54

1.0

—

Hypothyroidism, strict autoimmune

1.57

0.54

1.0

—

Any death

1.55

0.53

1.0

—

Sleep disorders (combined)

1.49

0.53

1.0

—

Hernia

1.54

0.53

1.0

—

Sleep apnoea, including avohilmo

1.51

0.52

1.0

—

Migraine

1.51

0.51

1.0

—

GASTRO-related operations

1.52

0.47

1.0

—

Any gastric operation

1.52

0.47

1.0

—

Acute tubulo-interstitial nephritis

1.44

0.46

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.46

0.45

1.1

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.44

0.44

1.0

—

Persons encountering health services for specific procedures and health care

1.42

0.44

1.1

1.0

—

Neurological diseases

1.45

0.44

1.0

1.1

—

Bronchitis

0.64

0.44

1.0

—

Coxarthrosis, primary

1.60

0.43

1.0

—

All-cause Heart Failure

1.58

0.42

1.0

—

Chronic periodontitis, complicated

1.57

0.42

1.0

—

Triptan medication for migraine, single purchase ok

1.39

0.42

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.39

0.42

1.0

—

Sulfonylureas

0.00

0.42

0.0

1.1

—

Appendicitis, broad definition

1.38

0.41

1.0

—

Diseases of appendix

1.37

0.41

1.0

—

Early onset COPD, excluding more controls

0.00

0.41

0.0

1.1

—

Focal epilepsy

0.00

0.41

0.0

1.1

—

Corneal ulcer

0.00

0.41

0.0

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.41

0.0

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

0.00

0.41

0.0

1.1

—

Somatoform disorder

0.00

0.41

0.0

1.1

—

Other and unspecified nonorganic psychotic disorders

0.00

0.41

0.0

1.1

—

Impingement syndrome of shoulder

0.00

0.41

0.0

1.1

—

Effects of foreign body entering through natural orifice

0.00

0.41

0.0

1.0

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.41

0.0

1.1

—

Type 1 diabetes, wide definition

0.00

0.41

0.0

1.1

—

L02BG Aromatase inhibitors

0.00

0.41

0.0

1.1

—

Poor fetal growth

0.00

0.40

0.0

1.0

—

Otitis externa

0.00

0.40

0.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.40

0.0

1.1

—

Type 1 diabetes

0.00

0.40

0.0

1.1

—

Phobic anxiety disorders

0.00

0.40

0.0

1.0

—

Genitourinary diseases

1.47

0.40

1.0

—

1.46

0.40

1.0

1.1

—

Nontoxic goitre/thyroid nodule

0.00

0.40

0.0

1.1

—

Combinations of oral blood glucose lowering drugs

0.00

0.40

0.0

1.1

—

Epilepsy

0.00

0.40

0.0

1.1

—

Heart failure, strict

1.45

0.39

1.0

—

Neoplasms

1.39

0.39

1.0

—

Injuries to the wrist and hand

1.40

0.39

1.0

—

Fall on same level

1.36

0.38

1.0

—

Gingivitis and periodontal diseases

1.33

0.38

1.0

1.1

—

Other specific joint derangements/joint disorders

1.33

0.38

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.38

0.38

1.0

—

Other soft tissue disorders, not elsewhere classified

1.39

0.37

1.0

—

Constipation

1.30

0.37

1.0

—

Malignant neoplasm, wide definition

0.65

0.37

1.2

1.0

—

Malignant neoplasm, including Hilmo

0.65

0.37

1.2

1.0

—

Renal tubulo-interstitial diseases

1.29

0.37

1.0

—

Stroke, including SAH

1.48

0.36

1.0

—

Diseases of arteries, arterioles and capillaries

1.47

0.36

1.0

—

Disorders of breast

1.47

0.36

1.0

—

Disorders of lens

1.43

0.36

1.2

1.0

—

Other heart diseases

1.39

0.35

1.0

—

Pure hypercholesterolaemia

1.36

0.34

1.0

—

Type 2 diabetes

0.68

0.34

1.0

—

Diabetes, varying definitions

0.68

0.34

1.0

—

Acute appendicitis, no complications

1.35

0.34

1.0

—

Other heart diseases, wide

1.37

0.32

1.0

—

Diseases of middle ear and mastoid

1.29

0.32

1.0

—

Bleeding

1.36

0.31

1.0

—

Hypertensive diseases

1.32

0.31

1.1

1.0

—

Hypertension

1.32

0.31

1.1

1.0

—

COPD/asthma/ILD related infections

1.34

0.31

1.0

—

COPD/asthma related infections

1.34

0.31

1.0

—

Type 2 diabetes, wide definition

1.30

0.30

1.0

—

Hard cardiovascular diseases

1.29

0.30

1.0

—

Injuries to the elbow and forearm

1.30

0.30

1.1

1.0

—

Other diseases of intestines

1.33

0.30

1.0

—

Other diseases of upper respiratory tract

1.33

0.30

1.0

—

Inflammatory diseases of female pelvic organs

1.26

0.30

1.0

—

Dizziness and giddiness

1.27

0.28

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.22

0.27

1.0

—

Asthma/COPD (KELA code 203)

1.20

0.25

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.74

0.25

1.0

—

Type 2 diabetes, definitions combined

0.73

0.25

1.0

—

Type 2 diabetes, strict (exclude DM1)

0.73

0.25

1.0

—

Abnormalities of breathing

0.71

0.25

1.0

—

Caries of enamel

1.18

0.24

1.0

—

Chronic apical periodontitis

1.28

0.24

1.0

—

Chronic lower respiratory diseases

1.26

0.24

1.0

—

Delivery

1.32

0.23

1.0

—

Senile cataract

1.32

0.23

1.2

1.0

—

Coxarthrosis [arthrosis of hip](FG)

1.32

0.23

1.0

—

Depression or dysthymia

1.30

0.23

1.0

—

Varicose veins

1.30

0.23

1.0

—

Coxarthrosis

1.29

0.23

1.0

—

Endocrine, nutritional and metabolic diseases

1.29

0.23

1.0

1.1

—

Acute sinusitis

1.30

0.23

1.0

—

Hypertensive diseases (excluding secondary)

1.26

0.23

1.2

1.0

—

Pain in throat and chest

1.29

0.23

1.0

—

Pregnancy hypertension

1.28

0.23

1.0

—

Asthma, unspecified (mode), excluding more controls

1.23

0.22

1.0

—

Provisional assignment of new diseases of uncertain etiology

1.24

0.22

1.0

—

Codes for special purposes

1.24

0.22

1.0

—

Status post-ami

0.00

0.22

0.0

1.0

—

Asthma, unspecified (mode)

1.20

0.22

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.21

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.0

—

Colorectal cancer

0.00

0.21

0.0

1.0

—

Congenital malformations of heart and great arteries

0.00

0.21

0.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.21

0.0

1.0

—

Acute laryngitis and tracheitis

0.00

0.21

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

0.00

0.21

0.0

1.1

—

Acne vulgaris

0.00

0.21

0.0

1.0

—

Failed induction of labour

0.00

0.21

0.0

1.0

—

Amenorrhoea

0.00

0.21

0.0

1.0

—

Obsessive-compulsive disorder

0.00

0.21

0.0

1.0

—

Ocular pain

0.00

0.21

0.0

1.0

—

Other specified and unspecified personality disorders

0.00

0.21

0.0

1.0

—

Twin gestation

0.00

0.21

0.0

1.0

—

Infectious mononucleosis, including avohilmo

0.00

0.21

0.0

1.0

—

Infectious mononucleosis

0.00

0.21

0.0

1.0

—

Multiple gestation

0.00

0.21

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.21

0.0

1.1

—

Other disorders of cornea

0.00

0.21

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.21

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

1.0

—

Benign neoplasm of breast

0.00

0.21

0.0

1.1

—

Other superficial mycoses, including avohilmo

0.00

0.21

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.21

0.0

1.0

—

Other disorders of the genitourinary system

0.00

0.21

0.0

1.1

—

Acute and transient psychotic disorders

0.00

0.21

0.0

1.0

—

Other/unspecified synovitis and tenosynovitis

0.00

0.21

0.0

1.1

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.0

—

FESS (DNB20)

0.00

0.21

0.0

1.0

—

Other disorders of kidney and ureter

0.00

0.21

0.0

1.0

—

Ethmoidectomy

0.00

0.21

0.0

1.1

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.0

—

Benign mammary dysplasia

0.00

0.21

0.0

1.1

—

Assault

0.00

0.21

0.0

1.0

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.21

0.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.21

0.0

1.1

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.1

—

Insulin, fast-acting (human)

0.00

0.21

0.0

1.0

—

Chondropathies

0.00

0.21

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

0.00

0.21

0.0

1.0

—

Trochanteric bursitis

0.00

0.21

0.0

1.1

—

Trigger finger

0.00

0.21

0.0

1.1

—

Atrophic disorders of skin

0.00

0.21

0.0

1.1

—

Schizophrenia

0.00

0.21

0.0

1.1

—

Superficial injury of hip and thigh

0.00

0.21

0.0

1.0

—

Zoster [herpes zoster]

0.00

0.21

0.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.21

0.0

1.0

—

Acute pancreatitis

0.00

0.21

0.0

1.1

—

Cardiac murmurs and other cardiac sounds

0.00

0.21

0.0

1.1

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.1

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.21

0.0

1.1

—

Salpingitis and oophoritis

0.00

0.21

0.0

1.1

—

Adhesive capsulitis of shoulder

0.00

0.21

0.0

1.1

—

DVT of lower extremities

0.00

0.21

0.0

1.1

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.1

—

Acute pancreatitis (for exclusion)

0.00

0.21

0.0

1.1

—

Implicit viral Sepsis

0.00

0.21

0.0

1.1

—

Viral Sepsis

0.00

0.21

0.0

1.1

—

Fibroblastic disorders

0.00

0.21

0.0

1.1

—

Eating disorder

0.00

0.21

0.0

1.0

—

Congenital malformations of the circulatory system

0.00

0.21

0.0

1.1

—

Lung cancer and mesothelioma

0.00

0.21

0.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.27

0.21

1.0

—

Colorectal cancer, including Hilmo

0.00

0.21

0.0

1.0

—

Fall on same level involving ice and snow

1.16

0.21

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

0.00

0.21

0.0

1.0

—

Use of memantine

0.00

0.21

0.0

1.0

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.0

—

Family history of malignant neoplasm

0.00

0.21

0.0

1.1

—

Bitten or struck by other mammals

0.00

0.21

0.0

1.0

—

Polyarthrosis

0.00

0.21

0.0

1.0

—

Superficial injury of ankle and foot

0.00

0.21

0.0

1.0

—

Myopia

0.00

0.21

0.0

1.0

—

Other disorders of eye and adnexa

0.00

0.21

0.0

1.1

—

Other disorders of patella

0.00

0.21

0.0

1.0

—

Nontoxic multinodular goitre

0.00

0.21

0.0

1.1

—

Early onset COPD

0.00

0.21

0.0

1.1

—

Social phobias

0.00

0.21

0.0

1.0

—

Focal epilepsy, strict definition

0.00

0.21

0.0

1.0

—

Acne

0.00

0.20

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.20

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

0.20

0.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.20

0.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.20

0.0

1.0

—

Tonsillectomy and adenotomy

1.26

0.20

1.0

1.1

—

Post-traumatic stress disorder

0.00

0.20

0.0

1.0

—

Other disorders of bone

0.00

0.20

0.0

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.20

0.0

1.1

—

Other diseases of the respiratory system

0.00

0.20

0.0

1.1

—

Other respiratory disorders and diseases

0.00

0.20

0.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.20

0.0

1.1

—

Personal history of other diseases and conditions

0.00

0.20

0.0

1.1

—

Asthma-related infections

1.24

0.20

1.0

—

Asthma, hospital admission 2, infections

1.24

0.20

1.0

—

Excessive attrition of teeth

1.24

0.20

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

0.20

0.0

1.1

—

Cholecystectomy

1.21

0.20

1.0

—

Benzodiazepine use

1.25

0.19

1.0

—

Appendectomy

1.16

0.19

1.0

—

Diseases of the respiratory system

1.21

0.18

1.0

—

Asthma, excluding more controls

1.20

0.18

1.0

—

Asthma (mode)

1.19

0.18

1.0

—

Asthma

1.16

0.18

1.0

—

Dentofacial anomalies [including malocclusion]

1.19

0.18

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.14

0.18

1.0

—

Complications of labour and delivery

0.75

0.17

1.0

—

Polyarthropathies

1.12

0.17

1.0

—

Other intervertebral disc disorders

0.73

0.17

1.0

—

Pain in limb

0.71

0.17

1.0

—

Exposure to other specified factors

0.74

0.17

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.14

0.16

1.0

—

1.14

0.16

1.0

—

Cholelithiasis

1.14

0.16

1.0

—

Psychiatric diseases

0.75

0.16

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

1.13

0.16

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.11

0.16

1.0

—

Other disorders of ear

0.79

0.16

1.0

—

Neurotic, stress-related and somatoform disorders

0.78

0.16

1.0

—

Anxiety disorders

0.78

0.16

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.17

0.16

1.0

—

Chronic periodontitis, including avohilmo

1.17

0.16

1.0

—

Periodontitis

1.17

0.15

1.0

—

Disorders of the thyroid gland

1.14

0.15

1.0

—

Dorsalgia

1.11

0.15

1.0

—

Diabetes medication

0.80

0.15

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.09

0.15

1.0

—

Codeine or tramadol medication

0.80

0.14

1.0

—

Heart failure, not strict

1.12

0.10

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.14

0.10

1.0

—

Other neurological diseases

1.11

0.10

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.11

0.10

1.0

—

Medical observation and evaluation for suspected diseases and conditions

1.06

0.09

1.0

—

Percutaneous Coronary Intervention

1.05

0.09

1.0

—

Coronary revascularization (ANGIO or CABG)

1.05

0.09

1.0

—

Diseases of the ear and mastoid process

1.15

0.09

1.0

—

Asthma (only as main-diagnosis), excluding more controls

1.11

0.09

1.0

—

Asthma (only as main-diagnosis)

1.08

0.09

1.0

—

Cardiac arrhythmias

1.04

0.08

1.0

—

Statin medication

0.83

0.08

1.0

—

Other nutritional deficiencies

1.05

0.08

1.0

—

Gonarthrosis,primary

0.79

0.08

1.0

—

Artificial joint operation, meniscal resection

0.80

0.08

1.0

—

Anxiety disorders, excluding more controls

0.78

0.08

1.0

—

Injuries to the ankle and foot

0.81

0.08

1.0

—

Low back pain

1.10

0.08

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.02

0.08

1.0

—

Solid cancers, including Hilmo

0.79

0.08

1.2

1.0

—

Disorders of eyelid, lacrimal system and orbit

0.84

0.08

1.2

1.0

—

Hypothyroidism, other/unspecified

1.09

0.07

1.0

—

Metabolic disorders

1.07

0.07

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.07

0.07

1.0

—

Other joint disorders

0.83

0.07

1.1

1.0

—

Other (not insulin) diabetes medications

0.86

0.07

1.0

—

Other dorsopathies, not elsewhere classified

1.09

0.07

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.85

0.07

1.1

1.0

—

Any event in cancer register

0.82

0.07

1.1

1.0

—

Mood [affective] disorders

0.83

0.07

1.0

—

Mood disorders

0.83

0.07

1.0

—

Soft tissue disorders

1.14

0.07

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.08

0.07

1.0

—

Arthropathies

1.03

0.07

1.1

1.0

—

Any mental disorder

0.85

0.07

1.0

—

Nerve, nerve root and plexus disorders

1.02

0.07

1.0

—

Influenza and pneumonia

0.88

0.07

1.0

—

Injuries to the head

0.85

0.07

1.1

1.0

—

Injuries to the knee and lower leg

1.10

0.04

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Non-small cell lung cancer

0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.0

1.0

—

Intermittent heterotropia

0.00

0.0

1.2

—

Excluding asthma or asthma-COPD overlap

0.97

0.00

1.0

—

Sequelae of injuries of upper limb

0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

0.0

1.0

—

All influenza (not pneumonia)

0.00

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

1.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.0

—

Hydronephrosis

0.00

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

1.0

—

Other juvenile arthritis

0.00

0.0

1.0

—

Adjustment and management of implanted device

0.00

0.0

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

1.0

—

Gonarthrosis

1.01

0.00

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

1.1

—

Other pulmonary diagnosis

0.97

0.00

1.0

—

Impacted maxillary molar

0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

0.0

1.0

—

Foreign body on external eye

0.00

0.0

1.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.0

1.0

—

Suggestive for eosinophilic asthma

0.00

0.0

1.0

—

Hypermobility syndrome

0.00

0.0

1.0

—

Other and unspecified injuries of ankle and foot

0.00

0.0

1.0

—

Eustachian salpingitis and obstruction

0.00

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.0

1.0

—

Hidradenitis suppurativa

0.00

0.0

1.0

—

COPD differential diagnosis

0.97

0.00

1.0

—

Sequelae of infectious and parasitic diseases, including avohilmo

0.00

0.0

1.0

—

Cervical polyps

0.00

0.0

1.0

—

Type 1 diabetes, definitions combined

0.00

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

0.0

1.0

—

Heartburn

0.00

0.0

1.1

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

0.00

0.0

1.0

—

Flat foot [pes planus] (acquired)

0.00

0.0

1.0

—

All kidney diseases

0.97

0.00

1.0

—

Malignant melanoma of skin

0.00

0.0

1.0

—

Other respiratory diseases principally affecting the interstitium

0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

0.0

1.0

—

Shoulder lesions

0.86

0.00

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Other metabolic disorders

0.00

-0.00

0.0

1.1

—

Neuromuscular dysfunction of bladder

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

Interstitial lung disease

0.00

-0.00

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

1.0

—

Astigmatism

0.00

-0.00

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict (exclude DM2)

0.00

-0.00

0.0

1.0

—

Other osteochondropathies

0.00

-0.00

0.0

1.0

—

Otitis externa, unspecified

0.00

-0.00

0.0

1.0

—

Hyperprolactinaemia

0.00

-0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.2

—

Other interstitial pulmonary diseases

0.00

-0.00

0.0

1.0

—

Benign neoplasm of eye and adnexa

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Schizoaffective disorder

0.00

-0.00

0.0

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.2

—

Congenital malformations and deformations of the musculoskeletal system

0.00

-0.00

0.0

1.1

—

Dissociative [conversion] disorders

0.00

-0.00

0.0

1.0

—

Mood disorders, excluding more controls

0.91

-0.00

1.0

—

Problems related to lifestyle

0.00

-0.00

0.0

1.0

—

Chronic diseases of tonsils and adenoids

0.95

-0.00

1.2

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.0

—

ILD differential diagnosis

0.97

-0.00

1.0

—

Maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.0

—

Asthma mixed form (mode)

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

-0.00

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgA [Presence] in Skin by Immunofluorescence

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS